Facultad de Medicina
Centro académico
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (9)
2023
-
Assessment of a Genomic Assay in Patients with ERBB2 -Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy with or Without Pertuzumab
JAMA Oncology, Vol. 9, Núm. 6, pp. 841-846
-
Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage
Frontiers in Oncology, Vol. 13
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses
BMC medicine, Vol. 18, Núm. 1, pp. 229
-
Response to Maccio et al, “Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?”
Journal of Thrombosis and Haemostasis
2019
-
Discovery of common and rare genetic risk variants for colorectal cancer
Nature Genetics, Vol. 51, Núm. 1, pp. 76-87
2016
2015
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12